DrugPatentWatch Database Preview
Biologic Drugs With Dosage Form: SYRINGE
» See Plans and Pricing
Details for Dosage Type: SYRINGE
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Amgen | NEUPOGEN | filgrastim | SYRINGE | 103353 | 003 | 1991-02-20 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
Amgen | NEUPOGEN | filgrastim | SYRINGE | 103353 | 003 | 1991-02-20 | Start Trial | 2039-02-26 | RX | search | ||
Amgen | NEUPOGEN | filgrastim | SYRINGE | 103353 | 003 | 1991-02-20 | Start Trial | University of the Sciences of Philadelphia (Philadelphia, PA) | 2034-11-21 | RX | search | |
Amgen | NEUPOGEN | filgrastim | SYRINGE | 103353 | 003 | 1991-02-20 | Start Trial | Washington University (St. Louis, MO) | 2034-04-01 | RX | search | |
Amgen | NEUPOGEN | filgrastim | SYRINGE | 103353 | 003 | 1991-02-20 | Start Trial | AMGEN INC. (Thousand Oaks, CA) | 2039-02-26 | RX | search | |
Amgen | NEUPOGEN | filgrastim | SYRINGE | 103353 | 003 | 1991-02-20 | Start Trial | 2036-04-01 | RX | search | ||
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |